blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP Citations: EP1708790

Cited inInternational search
Type:Patent literature
Publication No.:DE4039631  [X]
 (TROPONWERKE GMBH & CO KG [DE]) [X] 1-81 * claims 3,4,6 *;
Type:Patent literature
Publication No.:US5762960  [X]
 (DODMAN NICHOLAS H [US]) [X] 1-81 * column 9, line 39 * * column 9, line 59 * * column 10, lines 20-26 *;
Type:Patent literature
Publication No.:WO9843646  [X]
 (AKZO NOBEL NV [NL], et al) [X] 1-81 * page 2, line 25; claims 3,8 *;
Type:Patent literature
Publication No.:WO02051833  [A]
 (LUNDBECK & CO AS H [DK], et al) [A] 1-81 * page 4, lines 28-30 ** page 16, lines 15-21 *;
Type:Non-patent literature
Publication information:[X]  - VOLMAT R ET AL, "The treatment of depressions by Cledial. Evolution and clinical state and handwriting", PSYCHOLOGIE MEDICALE 1986 FRANCE, (1986), vol. 18, no. 10, pages 1615 - 1622, XP009028776 [X] 1-81 * page 1620 *
Type:Non-patent literature
Publication information:[X]  - SQUELART P ET AL, "Pipamperone (Dipiperon), a useful sedative neuroleptic drug in troublesome chronic psychotic patients.", ACTA PSYCHIATRICA BELGICA. BELGIUM 1977 MAR-APR, (197703), vol. 77, no. 2, ISSN 0300-8967, pages 284 - 293, XP009028314 [X] 1-81 * the whole document *
Type:Non-patent literature
Publication information:[X]  - DIEBOLD K. ET AL, "Are psychoactive-drug-induced changes in plasma lipid and lipoprotein levels of significance for clinical remission in psychiatric disorders?.", PHARMACOPSYCHIATRY, (1998) 31/2 (60-67)., (1998), XP009029360 [X] 1-81 * table 2 * * page 61, column 1 *
Type:Non-patent literature
Publication information:[X]  - KOCH H J ET AL, "Successful therapy of tardive dyskinesia in a 71-year-old woman with a combination of tetrabenazine, olanzapine and tiapride.", INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. ENGLAND MAR 2003, (200303), vol. 57, no. 2, ISSN 1368-5031, pages 147 - 149, XP009030046 [X] 1-81 * page 147, column 2, lines 1-3 *
Type:Non-patent literature
Publication information:[X]  - PERUGI G ET AL, "EFFECTIVENESS OF ADJUNCTIVE GABAPENTIN IN RESISTANT BIPOLAR DISORDER: IS IT DUE TO ANXIOUS-ALCOHOL ABUSE COMORBIDITY?", JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, WILLIAMS AND WILKINS, US, (2002), vol. 22, no. 6, ISSN 0271-0749, pages 584 - 591, XP009029358 [X] 1-81 * table 1 *
DOI: http://dx.doi.org/10.1097/00004714-200212000-00008
Type:Non-patent literature
Publication information:[X]  - ADLER L ET AL, "PRAXIS DER STATIONAEREN AKUTBEHANDLUNG VON MANIEN RETROSPEKTIVE VERGLEICHSUNTERSUCHUNG AN JE 100 PATIENTEN ZWEIER PSYCHIATRISCHER ZENTREN PRACTICE OF IN-PATIENT ACUTE TREATMENT OF MANIAS", FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, STUTTGART, DE, (1994), vol. 62, no. 12, ISSN 0720-4299, pages 479 - 488, XP009029389 [X] 1-81 * page 483, column 2, paragraph LAST *
Type:Non-patent literature
Publication information:[X]  - ANSOMS C ET AL, "Sleep disorders in patients with severe mental depression: double-blind placebo-controlled evaluation of the value of pipamperone (Dipiperon).", ACTA PSYCHIATRICA SCANDINAVICA. FEB 1977, (197702), vol. 55, no. 2, ISSN 0001-690X, pages 116 - 122, XP009041169 [X] 1-81 * abstract *
Type:Non-patent literature
Publication information:[X]  - LEYSEN J E ET AL, "RECEPTOR INTERACTI0NS OF NEW ANTIPSYCHOTICS: RELATION TO PHARMACODYNAMIC AND CLINICAL EFFECTS", INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, MARTIN DUNITZ, LONDON, GB, (1998), vol. 2, no. 1, ISSN 1365-1501, pages S03 - S17, XP001009585 [X] 1-81 * figure 2 *
Type:Non-patent literature
Publication information:[X]  - SCHOTTE A ET AL, "Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (1996), Database accession no. PREV199698829913, XP002290498 [X] 1-81 * abstract *
Type:Non-patent literature
Publication information:   [ ] - PSYCHOPHARMACOLOGY, (1996), vol. 124, no. 1-2, ISSN 0033-3158, pages 57 - 73
Type:Non-patent literature
Publication information:[X]  - VANHOENACKER P ET AL, "EFFICIENT EXPRESSION OF THE HUMAN DOPAMINE D4.2 RECEPTOR: POSITIVE INFLUENCE OF PIPAMPERONE ON EXPRESSION LEVELS", ABSTRACTS OF THE SOCIETY FOR NEUROSCIENCE, SOCIETY FOR NEUROSCIENCE, WASHINGTON, DC, US, (2000), vol. 26, no. 1/2, ISSN 0190-5295, page 1, XP001181469 [X] 1-81 * abstract *
Type:Non-patent literature
Publication information:[X]  - VIJVER VAN DE D A M C ET AL, "ANTIPSYCHOTICS AND PARKINSON'S DISEASE: ASSOCIATION WITH DISEASE AND DRUG CHOICE DURING THE FIRST 5 YEARS OF ANTIPARKINSONIAN DRUG TREATMENT", EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, SPRINGER VERLAG, DE, (2002), vol. 58, no. 7, ISSN 0031-6970, pages 157 - 161, XP009033980 [X] 1-81 * abstract * * page 158, paragraph RESULTS; tables 1,2 *
DOI: http://dx.doi.org/10.1007/s00228-002-0441-x
Type:Non-patent literature
Publication information:[X]  - ENGELBORGHS S ET AL, "AMINO ACIDS AND BIOGENIC AMINES IN CEREBROSPINAL FLUID OF PATIENTS WITH PARKINSON'S DISEASE", NEUROCHEMICAL RESEARCH, PLENUM PRESS, NEW YORK, US, (200308), vol. 28, no. 8, ISSN 0364-3190, pages 1145 - 1150, XP009031514 [X] 1-81 * abstract * * page 1147, column 1 *
DOI: http://dx.doi.org/10.1023/A:1024255208563
Type:Non-patent literature
Publication information:[X]  - ETCHEPAREBORDA M C, "Neurocognitive and pharmacological approach to specific learning disorders", EMBASE, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (1999), Database accession no. EMB-2000050033, XP002311106 [X] 1-81 * abstract *
Type:Non-patent literature
Publication information:   [ ] - REVISTA DE NEUROLOGIA 1999 SPAIN, (1999), vol. 28, no. SUPPL. 2, ISSN 0210-0010, pages S81 - S93
Type:Non-patent literature
Publication information:[X]  - WIRZ-JUSTICE A ET AL, "HALOPERIDOL DISRUPTS, CLOZAPINE REINSTATES THE CIRCADIAN REST-ACTIVITY CYCLE IN A PATIENT WITH EARLY-ONSET ALZHEIMER DISEASE", ALZHEIMER DISEASE AND ASSOCIATED DISORDERS, RAVEN PRESS, NEW YORK, NY, US, (2000), vol. 14, no. 4, ISSN 0893-0341, pages 212 - 215, XP009029353 [X] 1-81 * table 1 *
DOI: http://dx.doi.org/10.1097/00002093-200010000-00005
Type:Non-patent literature
Publication information:[X]  - FAHS H ET AL, "THYMOREGULATEURS DANS L'AGITATION ET LES TROUBLES DU COMPORTEMENT CHEZ LE SUJET DEMENT A PROPOS DE HUIT CAS ANTICONVULSIVANTS AND AGGRESSIVE BEHAVIORS IN ALZHEIMER'S DISEASE. EIGHT CASES REPORTS", ENCEPHALE, PARIS, FR, (1999), vol. 25, no. 2, ISSN 0013-7006, pages 169 - 174, XP009039295 [X] 1-81 * examples 1,3 *
Type:Non-patent literature
Publication information:[X]  - GRÖZINGER M ET AL, "Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine.", PHARMACOPSYCHIATRY. GERMANY JAN 2003, (200301), vol. 36, no. 1, ISSN 0176-3679, pages 3 - 6, XP009029363 [X] 1-81 * page 4, column 1 *
DOI: http://dx.doi.org/10.1055/s-2003-38084
Type:Non-patent literature
Publication information:[X]  - WERTH ESTHER ET AL, "Decline in long-term circadian rest-activity cycle organization in a patient with dementia.", JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY. 2002 SPRING, (200204), vol. 15, no. 1, ISSN 0891-9887, pages 55 - 59, XP009042127 [X] 1-81 * table 1 *
Type:Non-patent literature
Publication information:[PX]  - STAHL STEPHEN M ET AL, "Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer's disease.", CURRENT MEDICAL RESEARCH AND OPINION. APR 2004, (200404), vol. 20, no. 4, ISSN 0300-7995, pages 517 - 524, XP009041652 [PX] 1-81 * abstract * * table 2 *
DOI: http://dx.doi.org/10.1185/030079904125003214
Type:Non-patent literature
Publication information:[A]  - MELTZER HERBERT Y ET AL, "Plasma clozapine levels and the treatment of L-DOPA-induced psychosis in Parkinson's disease. A high potency effect of clozapine", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (1995), Database accession no. PREV199598192811, XP002290499 [A] 1-81 * abstract *
Type:Non-patent literature
Publication information:   [ ] - NEUROPSYCHOPHARMACOLOGY, (1995), vol. 12, no. 1, ISSN 0893-133X, pages 39 - 45
Type:Non-patent literature
Publication information:[A]  - MUENCHAU A ET AL, "PHARMACOLOGICAL TREATMENT OF PARKINSON'S DISEASE", POSTGRADUATE MEDICAL JOURNAL, MCMILLAN PRESS, BASINGSTOKE, GB, (200010), vol. 76, no. 900, ISSN 0032-5473, pages 602 - 610, XP009034316 [A] 1-81 * the whole document *
DOI: http://dx.doi.org/10.1136/pmj.76.900.602
Type:Non-patent literature
Publication information:[A]  - FALTRACO F ET AL, "AKTUELLE THERAPIEMOEGLICHKEITEN DER ALZHEIMER DEMENZ CURRENT THERAPEUTICAL STRATEGIES IN DEMENTIA", NEUROLOGIE UND REHABILITATION, BONN, DE, (2003), vol. 9, no. 1, ISSN 0947-2177, pages 15 - 22, XP009041267 [A] 1-81 * the whole document *
Cited inExamination
Type:Non-patent literature
Publication information:   - WIELING W ET AL, "INITIAL ORTHOSTATIC HYPOTENSION AS A CAUSE OF RECURRENT SYNCOPE: A CASE REPORT", CLINICAL AUTONOMIC RESEARCH, RAPID COMMUNICATIONS, Oxford, GB, (2001), vol. 11, no. 4, pages 269 - 270, XP009039296
Type:Non-patent literature
Publication information:   - FOUKS D ET AL, "TRAITEMENT DES TROUBLES CARACTERIELS PAR UNE NOUVELLE BUTYROPHENONE:LE R. 3345 OU PIPAMPERONE", ANNALES MEDICO-PSYCHOLOGIQUES, FORTIN, PARIS, FR, (1996), vol. 124, no. 5, pages 677 - 681
Type:Non-patent literature
Publication information:   - URL: http://www.biam2.org/www/Sub2783.html
Type:Non-patent literature
Publication information:   - URL: http://www.adiph.org/pic/pedia-neuroleptiques.pdf
Type:Non-patent literature
Publication information:   - FITZGERALD K D, "Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder", JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, UNITED STATES, (1999), vol. 9, no. 2, pages 115 - 123
Type:Non-patent literature
Publication information:   - MCDOUGLE, "A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder", ARCHIVES OF GENERAL PSYCHIATRY, (2000), vol. 57, no. 8, pages 794 - 801
Type:Non-patent literature
Publication information:   - MAINA GIUSEPPE, "Antipsychotic augmentation for treatment resistant obsessive-compulsive disorder: What if antipsychotic is discontinued?", INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, (2003), vol. 18, no. 1, pages 23 - 28
Type:Non-patent literature
Publication information:   - HIROSE SHIGEHIRO, "An open pilot study combining risperidone and a selective serotonin reuptake inhibitor as initial antidepressant therapy", THE JOURNAL OF CLINICAL PSYCHIATRY, US, (2002), vol. 63, no. 8, pages 733 - 736